Prescription drug · ANDA
Gavilyte-N NDC 43386-050
Polyethylene glycol 3350 420 g/438.4g + 3 more ingredients · Powder, For solution · Oral · Lupin Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43386-050-19 | 43386005019 | 438.4 g in 1 BOTTLE (43386-050-19)Marketed from May 28, 2009 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gavilyte-N
- Generic name (nonproprietary)
- polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate
- Active ingredients
- Polyethylene glycol 3350 — 420 g/438.4gSodium chloride — 11.2 g/438.4gSodium bicarbonate — 5.72 g/438.4gPotassium chloride — 1.48 g/438.4g
- Dosage form
- Powder, For solution
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals,Inc.NDC labeler code 43386
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090019
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 43386-050_3839c7fd-e7c4-45c6-ae02-0302b40046b0SPL ID 3839c7fd-e7c4-45c6-ae02-0302b40046b0SPL set ID 27195187-75a3-431f-90d9-84da1b94e849RxCUI 801054, 979099UNII G2M7P15E5P, 451W47IQ8X, 8MDF5V39QO, 660YQ98I10
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443386005019followed by a unit qualifier and the quantityPackage 43386-0050-19. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
GaviLyte-N is a combination of PEG 3350, an osmotic laxative, and electrolytes indicated for cleansing of the colon in preparation for colonoscopy in adults and pediatric patients aged 6 months or greater ( 1 ) GaviLyte-N is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater.
Excerpt only. Read the full label for complete information.
About NDC 43386-050
- What is NDC 43386-050?
- 43386-050 is the product NDC for Gavilyte-N, Polyethylene glycol 3350 420 g/438.4g + 3 more ingredients powder, for solution, listed with the FDA by Lupin Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Gavilyte-N (Polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate).
- What is the active ingredient?
- Polyethylene glycol 3350, Sodium chloride, Sodium bicarbonate, Potassium chloride.
- Who is the labeler?
- Lupin Pharmaceuticals,Inc., NDC labeler code 43386. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Gavilyte-N?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.